[Form 4] Enact Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Genworth Holdings, Inc. reported the sale of 940,819 shares of Enact Holdings, Inc. common stock on 10/31/2025 at $36.1934 per share. The transaction was effected pursuant to a Share Repurchase Agreement dated April 30, 2025.

Following the sale, Genworth beneficially owns 117,010,462 Enact shares and is identified as a Director and 10% Owner. The filing notes Genworth owns approximately 81% of Enact’s outstanding common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Genworth Holdings, Inc.

(Last) (First) (Middle)

11011 WEST BROAD STREET

(Street)

GLEN ALLEN VA 23060

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enact Holdings, Inc. [ ACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/31/2025		S(1)		940,819	D	$36.1934(2)	117,010,462	D(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Share Repurchase Agreement between Enact Holdings, Inc. (the "Issuer") and Genworth Holdings, Inc. dated as of April 30, 2025 (the "Agreement"). A copy of the Agreement can be found as exhibit 10.1 to the Issuer's Form 10-Q for the quarterly period ended March 31, 2025, on the SEC's website at: https://www.sec.gov/Archives/edgar/data/1823529/000182352925000124/enact-genworthrepurchaseag.htm.

2. Represents a price per share determined pursuant to the terms of the Agreement, based on a weighted average price paid by the Issuer for purchases from third-parties.

3. Genworth Holdings, Inc. owns approximately 81% of the outstanding shares of common stock of the Issuer.

Remarks:

	/s/ Lisa J. Baldyga, Vice President and Treasurer on behalf of Genworth Holdings, Inc.	11/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Genworth Holdings report in this Form 4 for ACT?

A sale of 940,819 Enact common shares on 10/31/2025 at $36.1934 per share.

How many Enact (ACT) shares does Genworth hold after the transaction?

Genworth beneficially owns 117,010,462 shares following the reported sale.

What agreement governed the reported sale of Enact shares?

A Share Repurchase Agreement between Enact Holdings, Inc. and Genworth Holdings, Inc. dated April 30, 2025.

What is Genworth’s relationship to Enact in this filing?

Genworth is identified as a Director and 10% Owner.

What percentage of Enact’s outstanding shares does Genworth own?

Approximately 81% of Enact’s outstanding common stock.

What is the issuer and ticker mentioned?

The issuer is Enact Holdings, Inc. with ticker ACT.

Where can the repurchase agreement be found?

As exhibit 10.1 to Enact’s Form 10‑Q for the quarter ended March 31, 2025 at the SEC link provided.